Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1980-05-02
1981-09-22
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
435235, 435236, 435238, 435239, A61K 39265
Patent
active
042910196
ABSTRACT:
A vaccine for infectious bovine rhinotracheitis (IBR) is prepared by non-ionic detergent extraction of IBR virus infected cells. The extracted viral envelope protein can be prepared in injectable dose form by combination with an oil-type adjuvant. The vaccine produces a high level of antibody response, and is capable of eliminating virus shed for animals infected after immunization.
REFERENCES:
patent: 4158054 (1979-06-01), Furminger et al.
Lupton et al., Am. J. Vbt. Res., 41 (3): 383-390, Mar. 1980, Evaluation of Experimental Subunit Vaccines for Infectious Bovine Rhinotracheitis.
Vester Gaard et al., J. Virol. 24 (1): 82-90, Oct. 1977, Crossed Immunoelectrophoretic Studies of the Solubility and Immunogenicity of Herpes Simplex Virus Antigens.
Cappel Arch Virol. 52: 29-35, (1976), Comparison of the Humoral and Cellular Immune Responses After Immunization with Live, Uninactivated Herpes Simplex Virus and a Subunit Vaccine and Efficacy of these Immunizations.
Kaplan et al., Progr. Med. Virol. 21: 1-12 (1975), Excretion of Specific Glycoproteins by Cells Infected with Herpes Simplex Virus, Types 1 and 2.
Buxton et al., Animal Microbiology, vol. 2, Blackwell Sci. Pub. Ltd., Oxford, UK., (1977), pp. 407-427, 737-740, 745-747.
Lupton Harold W.
Reed David E.
Iowa State University & Research Foundation, Inc.
Rose Shep K.
LandOfFree
Vaccine for infectious bovine rhinotracheitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine for infectious bovine rhinotracheitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for infectious bovine rhinotracheitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-335143